GlassScriptPhysician profile
Vinod K Garg
NPI 1962578120
$28,640.36
in general payments reported to CMS, 2019-2025
27 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $141 · 2021: $21K · 2022: $377 · 2023: $414 · 2024: $5,472 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $2,130 · Food and Beverage: $1,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $2,130.32 |
| Food and Beverage | $1,390.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,875.97 | 2019-2024 | |
| Smith+Nephew, INC. | $906.37 | 2019-2025 | Collagenase Santyl, Stravix, Grafix |
| W. L. Gore & Associates, INC. | $404.39 | 2024 | Gore Bio-A Tissue Reinforcement |
| Abbvie INC. | $211.37 | 2022-2025 | |
| Trevena, INC. | $172.02 | 2021 | |
| Polynovo North America LLC | $151.13 | 2021-2022 | |
| Covidien LP | $143.67 | 2019 | |
| Baxter Healthcare | $133.58 | 2019-2024 | Tisseel, Floseal |
| Mallinckrodt Hospital Products INC. | $112.49 | 2020-2021 | |
| Lemaitre Vascular, INC. | $56.90 | 2019 | |
| Tela Bio, INC. | $50.17 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acell, INC. | $43.21 | 2019 | |
| Ethicon US, LLC | $40.32 | 2019-2021 | |
| Stryker Corporation | $38.74 | 2022 | |
| Integra Lifesciences Corporation | $36.20 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $32.79 | 2023-2024 | |
| Mimedx Group, INC. | $31.59 | 2024 | |
| Kci USA, INC. | $30.03 | 2020 | |
| Becton, Dickinson and Company | $28.65 | 2024 | |
| Merck Sharp & Dohme LLC | $25.62 | 2024 | Bridion |
| Medtronic, INC. | $23.14 | 2021 | |
| Heron Therapeutics, INC. | $22.57 | 2022 | |
| Mallinckrodt Enterprises LLC | $16.54 | 2019 | |
| Organogenesis INC. | $14.98 | 2021 | |
| Boston Scientific Corporation | $13.34 | 2020 | |
| Daiichi Sankyo INC. | $12.31 | 2019 | |
| Allergan, INC. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinod Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.